" /> Fanconi anemia, complementation group d2 - CISMeF





Preferred Label : Fanconi anemia, complementation group d2;

Symbol : FANCD2;

CISMeF acronym : FACD; FAD2; FANCD; FANCD2; FA4;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Fanconi pancytopenia, type 4; Fanconi anemia, complementation group D; FAD2; FA4; FANCD; FACD;

Description : Fanconi anemia (FA) is a clinically and genetically heterogeneous disorder that causes genomic instability. Characteristic clinical features include developmental abnormalities in major organ systems, early-onset bone marrow failure, and a high predisposition to cancer. The cellular hallmark of FA is hypersensitivity to DNA crosslinking agents and high frequency of chromosomal aberrations pointing to a defect in DNA repair (summary by Deakyne and Mazin, 2011). For additional general information and a discussion of genetic heterogeneity of Fanconi anemia, see 227650.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the Fanconi anemia, complementation group D2 gene (FANCD2, 613984.0001);

Neoplasia : Leukemia;

Laboratory abnormalities : Multiple chromosomal breaks; Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C; Deficient excision of UV-induced pyrimidine dimers in DNA; Prolonged G2 phase of cell cycle;

Prefixed ID : #227646;

Details


You can consult :


Nous contacter.
28/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.